Download PDF
Schlaf 2014; 03(03): 179-180
DOI: 10.1055/s-0038-1626108
Pharmakotherapie in der Praxis
Schattauer GmbH

Betablocker & Schlaf

Mina C. Hinsch
1   Klinik u. Poliklinik für Psychiatrie und Psychotherapie Albert-Schweitzer-Camp. 148149 Münster Tel. 0251/8356601, Email: minacarolina.hinsch@ukmuenster.de
› Author Affiliations
Further Information

Publication History

Publication Date:
12 February 2018 (online)

    Permissions and Reprints

Ein Viertel aller Deutschen leidet an Hypertonie, in der Altersgruppe der über 65-Jährigen sind es bis zu 50 % der Gesamtbevölkerung (16). Hypertonus ist als Risikofaktor für Herz-Kreislauf-Erkrankungen seit langem bekannt. Antihypertensiva, wie die hier besprochenen Betablocker, zählen fachdisziplinübergreifend zu den am häufigsten verschriebenen Medikamenten.

 

  • Literatur

  • 1 Ahmed AI, van Mierlo P, Jansen P. Sleep disorders, nightmares, depression and anxiety in an elderly patient treated with low-dose metoprolol. Gen Hosp Psychiatry 2010; 32 (06) 646. e, 5–7.
    Google Scholar
  • 2 Caples SM. Sleep disordered breathing in heart failure: a contemporary assessment. J Clin Sleep Med 2008; 4 (01) 43-44.
    PubMedGoogle Scholar
  • 3 Chang CH, Yang YH, Lin SJ, Su JJ, Cheng CL, Lin LJ. Risk of insomnia attributable to -blockers in elderly patients with newly diagnosed hypertension. Drug Metab Pharmacokinet 2013; 28 (01) 53-58.
    CrossrefPubMedGoogle Scholar
  • 4 Grote L. (Antihypertensive medication and sleep). Dtsch Med Wochenschr. 1998; 123 (46) 1389-1394.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Hensel J, Pillmann F. Late-life somnambulism after therapy with metoprolol. Neuropharmacol 2008; 31 (04) 248-250.
    CrossrefPubMedGoogle Scholar
  • 6 Iranzo A, Santamaria J. Bisoprolol-induced rapid eye movement sleep behavior disorder. Am J Med 1999; 107 (04) 390-392.
    CrossrefPubMedGoogle Scholar
  • 7 Köhnlein T, Welte T. Does beta-blocker treatment influence central sleep apnoea?. Respir Med 2007; 101 (04) 850-853.
    CrossrefPubMedGoogle Scholar
  • 8 Maebara C, Ohtani H, Sugahara H, Mine K, Kubo C, Sawada Y. Nightmares and panic disorder associated with carvedilol overdose. Ann Pharmacother 2002; 36 (11) 1736-1740.
    CrossrefPubMedGoogle Scholar
  • 9 Morrison I, Frangulyan R, Riha RL. Beta-blockers as a cause of violent rapid eye movement sleep behavior disorder: a poorly recognized but common cause of violent parasomnias. Am J Med. 2011; 124 (01) e11.
    PubMedGoogle Scholar
  • 10 Scheer FA, Morris CJ, Garcia JI, Smales C, Kelly EE, Marks J, Malhotra A, Shea SA. Repeated melatonin supplementation improves sleep in hypertensive patients treated with beta-blockers: a randomized controlled trial. Sleep 2012; 35 (10) 1395-1402.
    CrossrefPubMedGoogle Scholar
  • 11 Silva CP, Lorenzi-Filho G, Marcondes B, Osmundo Jr. G, Mangini S, Freitas Jr. AF, Pires PV, Bocchi EA, Bacal F. (Reduction of central sleep apnea in heart failure patients with beta-blockers therapy). Arq Bras Cardiol 2010; 94 (02) 223-229 229–232, 239–245,.
    PubMedGoogle Scholar
  • 12 Tamura A, Kawano Y, Kadota J. Carvedilol reduces the severity of central sleep apnea in chronic heart failure. Circ J 2009; 73 (02) 295-298.
    CrossrefPubMedGoogle Scholar
  • 13 Thachil J, Zeller JR, Kochar MS. Hypersomnolence with beta-adrenergic blockers. Chest 1987; 92 (05) 943-944.
    CrossrefPubMedGoogle Scholar
  • 14 Yilmaz MB, Erdem A, Yalta K, Turgut OO, Yilmaz A, Tandogan I. Impact of beta-blockers on sleep in patients with mild hypertension: a randomized trial between nebivolol and metoprolol. Adv Ther 2008; 25 (09) 871-883.
    CrossrefPubMedGoogle Scholar
  • 15 Yontar OC, Erdem A, Yilmaz MB. Sleep quality in patients with hypertension: additional negative effect of drug therapy. Sleep Med 2009; 10 (10) 1168.
    PubMedGoogle Scholar
  • 16 www.rki.de/DE/Content/Gesundheitsmonitoring/Gesundheitsberichterstattung/GBEDownloadsB/Geda2010/Bluthochdruck.pdf?__blob=publicationFile (Letzter Zugriff 12.08.2014)